全文获取类型
收费全文 | 1694篇 |
免费 | 142篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 72篇 |
妇产科学 | 34篇 |
基础医学 | 241篇 |
口腔科学 | 12篇 |
临床医学 | 245篇 |
内科学 | 305篇 |
皮肤病学 | 27篇 |
神经病学 | 152篇 |
特种医学 | 52篇 |
外科学 | 155篇 |
综合类 | 18篇 |
一般理论 | 1篇 |
预防医学 | 268篇 |
眼科学 | 57篇 |
药学 | 101篇 |
中国医学 | 3篇 |
肿瘤学 | 89篇 |
出版年
2024年 | 3篇 |
2023年 | 19篇 |
2022年 | 24篇 |
2021年 | 64篇 |
2020年 | 34篇 |
2019年 | 52篇 |
2018年 | 43篇 |
2017年 | 43篇 |
2016年 | 61篇 |
2015年 | 50篇 |
2014年 | 60篇 |
2013年 | 91篇 |
2012年 | 155篇 |
2011年 | 149篇 |
2010年 | 77篇 |
2009年 | 75篇 |
2008年 | 121篇 |
2007年 | 110篇 |
2006年 | 99篇 |
2005年 | 83篇 |
2004年 | 86篇 |
2003年 | 92篇 |
2002年 | 70篇 |
2001年 | 15篇 |
2000年 | 6篇 |
1999年 | 10篇 |
1998年 | 17篇 |
1997年 | 14篇 |
1996年 | 10篇 |
1995年 | 12篇 |
1994年 | 6篇 |
1993年 | 6篇 |
1992年 | 6篇 |
1991年 | 6篇 |
1989年 | 3篇 |
1988年 | 7篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 7篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1981年 | 4篇 |
1980年 | 4篇 |
1974年 | 3篇 |
1973年 | 2篇 |
1972年 | 5篇 |
1964年 | 4篇 |
1962年 | 2篇 |
1960年 | 2篇 |
1941年 | 2篇 |
排序方式: 共有1844条查询结果,搜索用时 195 毫秒
21.
Jean-Sylvain Hermida Emmanuel Tcheng Genevieve Jarry Veronique Moullart Sylvie Arlot Jean-Luc Rey Jean Delonca Claire Schvartz 《Europace : European pacing, arrhythmias, and cardiac electrophysiology》2004,6(2):169-174
Amiodarone-induced thyrotoxicosis (AIT) is a common complication of amiodarone therapy. Although permanent withdrawal of amiodarone is recommended due notably to the risk of worsening of tachyarrhythmias, some patients may require the reintroduction of amiodarone several months after normalizing their thyroid function. We, retrospectively, assessed the effects of (131)I therapy to prevent recurrence of AIT in euthyroid patients requiring reintroduction of amiodarone. SUBJECTS AND METHODS: Amiodarone was required in 10 cases of recurrent symptomatic paroxysmal atrial fibrillation (AF) and in 5 cases of ventricular tachycardia (VT) (M = 12, F = 3, mean age: 63 +/- 14). The underlying heart disease was dilated cardiomyopathy (n = 4), ischaemic heart disease (n = 4), hypertensive heart disease (n = 2), arrhythmogenic right ventricular dysplasia (n = 27) and valvulopathy (n = 1). Two patients had idiopathic paroxysmal AF. RESULTS: A mean (131)I dose of 579 +/- 183 MBq was administered 34 +/- 37 after the episode of AIT. Amiodarone was reintroduced in 14 of 15 patients after a mean interval of 103 +/- 261 d. Fourteen patients developed definite hypothyroidism necessitating l-thyroxine but we observed no late recurrence of AIT. After a mean follow-up of 22 +/- 16 months, tachyarrhythmias were controlled in 12 of 14 patients. CONCLUSION: (131)I therapy appears to be an effective and safe approach to prevent the recurrence of AIT in a patient requiring the reintroduction of amiodarone for tachyarrhythmias. 相似文献
22.
Jokubaitis VJ Sinka L Driessen R Whitty G Haylock DN Bertoncello I Smith I Péault B Tavian M Simmons PJ 《Blood》2008,111(8):4055-4063
Previous studies revealed that mAb BB9 reacts with a subset of CD34(+) human BM cells with hematopoietic stem cell (HSC) characteristics. Here we map BB9 expression throughout hematopoietic development and show that the earliest definitive HSCs that arise at the ventral wall of the aorta and surrounding endothelial cells are BB9(+). Thereafter, BB9 is expressed by primitive hematopoietic cells in fetal liver and in umbilical cord blood (UCB). BB9(+)CD34(+) UCB cells transplanted into nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice contribute 10-fold higher numbers of multilineage blood cells than their CD34(+)BB9(-) counterparts and contain a significantly higher incidence of SCID-repopulating cells than the unfractionated CD34(+) population. Protein microsequencing of the 160-kDa band corresponding to the BB9 protein established its identity as that of somatic angiotensin-converting enzyme (ACE). Although the role of ACE on human HSCs remains to be determined, these studies designate ACE as a hitherto unrecognized marker of human HSCs throughout hematopoietic ontogeny and adulthood. 相似文献
23.
24.
25.
Danielle Hitch Michelle Taylor Genevieve Pepin 《Scandinavian journal of occupational therapy》2015,22(3):216-225
Aims. This aim of this study was to obtain a consensus from clinicians regarding occupational therapy for people with depression, for the assessments and practices they use that are not currently supported by research evidence directly related to functional performance. The study also aimed to discover how many of these assessments and practices were currently supported by research evidence. Methods. Following a previously reported systematic review of assessments and practices used in occupational therapy for people with depression, a modified nominal group technique was used to discover which assessments and practices occupational therapists currently utilize. Three online surveys gathered initial data on therapeutic options (survey 1), which were then ranked (survey 2) and re-ranked (survey 3) to gain the final consensus. Twelve therapists completed the first survey, whilst 10 clinicians completed both the second and third surveys. Major findings. Only 30% of the assessments and practices identified by the clinicians were supported by research evidence. A consensus was obtained on a total of 35 other assessments and interventions. These included both occupational-therapy-specific and generic assessments and interventions. Principle conclusion. Very few of the assessments and interventions identified were supported by research evidence directly related to functional performance. While a large number of options were generated, the majority of these were not occupational therapy specific. 相似文献
26.
Nicholas E. Ingraham Laura N. Purcell Basil S. Karam R. Adams Dudley Michael G. Usher Christopher A. Warlick Michele L. Allen Genevieve B. Melton Anthony Charles Christopher J. Tignanelli 《Journal of general internal medicine》2021,36(11):3462
BackgroundDespite past and ongoing efforts to achieve health equity in the USA, racial and ethnic disparities persist and appear to be exacerbated by COVID-19.ObjectiveEvaluate neighborhood-level deprivation and English language proficiency effect on disproportionate outcomes seen in racial and ethnic minorities diagnosed with COVID-19.DesignRetrospective cohort studySettingHealth records of 12 Midwest hospitals and 60 clinics in Minnesota between March 4, 2020, and August 19, 2020PatientsPolymerase chain reaction–positive COVID-19 patientsExposuresArea Deprivation Index (ADI) and primary languageMain MeasuresThe primary outcome was COVID-19 severity, using hospitalization within 45 days of diagnosis as a marker of severity. Logistic and competing-risk regression models assessed the effects of neighborhood-level deprivation (using the ADI) and primary language. Within race, effects of ADI and primary language were measured using logistic regression.ResultsA total of 5577 individuals infected with SARS-CoV-2 were included; 866 (n = 15.5%) were hospitalized within 45 days of diagnosis. Hospitalized patients were older (60.9 vs. 40.4 years, p < 0.001) and more likely to be male (n = 425 [49.1%] vs. 2049 [43.5%], p = 0.002). Of those requiring hospitalization, 43.9% (n = 381), 19.9% (n = 172), 18.6% (n = 161), and 11.8% (n = 102) were White, Black, Asian, and Hispanic, respectively. Independent of ADI, minority race/ethnicity was associated with COVID-19 severity: Hispanic patients (OR 3.8, 95% CI 2.72–5.30), Asians (OR 2.39, 95% CI 1.74–3.29), and Blacks (OR 1.50, 95% CI 1.15–1.94). ADI was not associated with hospitalization. Non-English-speaking (OR 1.91, 95% CI 1.51–2.43) significantly increased odds of hospital admission across and within minority groups.ConclusionsMinority populations have increased odds of severe COVID-19 independent of neighborhood deprivation, a commonly suspected driver of disparate outcomes. Non-English-speaking accounts for differences across and within minority populations. These results support the ongoing need to determine the mechanisms that contribute to disparities during COVID-19 while also highlighting the underappreciated role primary language plays in COVID-19 severity among minority groups.Supplementary InformationThe online version contains supplementary material available at 10.1007/s11606-021-06790-w. 相似文献
27.
28.
Charles N. S. Chan Jacques Berland Alain Cribier Paolo Rocha Gunter Stix Genevieve Derumeaux Brice Letac 《Catheterization and cardiovascular interventions》1994,32(3):223-230
Patients with mitral stenosis in Western countries are relatively old. It is anticipated that percutaneous transseptal mitral commissurotomy (PTMC) may have more complications and may not be as effective in this group of patient as in younger patients due to more calcification and fibrosis of the mitral valve. We analysed the clinical, hemodynamic, echocardiographic data in 296 consecutive patients divided prospectively into two groups; group 1 consisted of 184 patients ≥ 40 years and group 2 of 112 patients < 40 years coming mostly from developing countries. The immediate gain in valve area was 2.18 ± 0.61 cm2 in group 1 vs. 2.31 ± 0.65 cm2 in group 2 (P = ns). The incidence of acute regurgitation requiring surgical intervention was similar in both groups. Follow-up data up to 5 years after PTMC was available in 170 patients (92.4%) in group 1 (mean 20 ± 13 months) and 83 patients (74.1%) in group 2 (mean 29 ± 17 months). Restenosis by Doppler method (valve area less than 1.5 cm2 with loss of at least 50% initial gain in valve area) was found in 33 patients in group 1 (29.2%) vs. 11 (14.9%) in group 2 (P < 0.05). Events free from death, need for mitral valve replacement or repeat PTMC at 5 year follow-up was 76% in group 1 vs. 87% in group 2 (P < 0.05). We conclude that the immediate effectiveness and acute complications of PTMC in patients 40 years and above are comparable to younger patients. Restenosis is clearly higher and there is a trend towards need for mitral valve replacement in patients 40 years and above at follow-up. However, the continuing benefit for the majority of the patients 40 years and above (76% free from adverse events) would suggest that PTMC is an appropriate treatment modality even in the older patients. © 1994 Wiley-Liss,Inc.. 相似文献
29.
30.